Valeant, the acquisitive pharmaceutical company under scrutiny over its accounting practices, has replaced its general counsel and announced the exit of the company's PR and IR chief.
Laurie Little, senior VP of investor relations for Valeant who manages global communications for the Quebec-based company, is stepping down after nine years.
Valeant has brought on investment manager Scott Hirsch as senior VP of business straegy and communications. "His insights into the sector and knowledge of Valeant's businesses will be invaluable as we take further action to stabilize and transform the company," said CEO Joseph Papa.
Also today the company said it tapped Novartis' Christina Ackermann as executive VP and general counsel. She was recently senior VP and general counsel for Novartis' Alcon unit.
General counsel Robert Chai-Onn is out after a transition.
Valeant in December added Washington-based Vianovo to its PR defense, on top of Sard Verbinnen & Co., as its business strategy and accounting were criticized by activist Bill Ackman -- who said PR was a major problem of the company -- and the company was drawn into a larger debate over high drug prices.
Senior leaders have been exiting newly combined agencies since the wave of integrations started—the kind of departures that don't always make headlines but show up in who's running client accounts six months later.
Why CEO visibility is no longer optional as a communications tactic.
The “waiting period” that was once set aside for CEOs to develop their strategies before facing media scrutiny may be better used for corporate comms leaders get to know their CEO and what his or her short-term priorities will be.
Senior-most communications executives in the Fortune 500 earned between $50,000 and $100,000 more this year than they did two years ago, according to a recent survey of chief communications officers.
